Skip to content

Cervical cancer symptoms, causes, progression, and treatment options explained

Cervical Cancer Insights: Symptoms, Causes, Stages of Progression, and Treatment Options

Cervical Cancer: Signs, Causes, Stages of Progression, and Available Treatment Options
Cervical Cancer: Signs, Causes, Stages of Progression, and Available Treatment Options

Cervical cancer symptoms, causes, progression, and treatment options explained

In the realm of women's health, cervical cancer is a significant concern, but with regular screening and vaccination, the risk can be significantly reduced. The Centers for Disease Control and Prevention (CDC) offers guidelines for cervical cancer screening and HPV vaccination, aiming to protect women and lower the incidence of cervical cancer.

For women aged 21-29 years, the CDC recommends a Pap smear every three years as a screening method. As women reach the age of 30-65 years, they have the option to choose from various screening methods: HPV testing alone every five years, co-testing (Pap smear plus HPV test) every five years, or a Pap smear alone every three years. Screening can generally stop after age 65 if there is a history of adequate negative screening results and no history of cervical precancer or cancer. Women who have undergone a hysterectomy with removal of the cervix and have no history of cervical cancer may not require further screening.

Regarding HPV vaccination, the CDC recommends routine vaccination for adolescents aged 11-12 years. The vaccine can be given starting as early as 9 years old. Catch-up vaccination is recommended for those who missed the vaccine at the recommended age, generally up to age 26. For immunocompromised individuals and some adults aged 27-45 years, vaccination may be considered based on discussion with a healthcare provider. The vaccine currently available in the U.S. is Gardasil 9, which protects against 9 HPV types responsible for most cervical cancers and other HPV-related diseases. The standard vaccination schedule is a two-dose series for those starting before age 15 and a three-dose series for those starting at age 15 or older.

Cervical cancer is most commonly diagnosed using the FIGO system. The American Cancer Society (ACS) estimates that healthcare professionals will make over 4,000 diagnoses of invasive cervical cancer in 2019. Regular cervical screening might help a person identify and deal with signs of cancer before the condition can develop or spread too far. Using a condom during sex and delaying first sexual intercourse can also lower the risk of HPV infection.

Early-stage cervical cancer options may include surgery and radiation therapy. Advanced cervical cancer requires more extensive treatment, which will typically involve either radiation therapy or a combination of radiation therapy and chemotherapy. Participating in a clinical trial may be the best treatment option for some people.

It is essential to note that side effects of chemotherapy and radiation therapy can vary, and they depend on the specific drug. Side effects may include nausea, vomiting, hair loss, fatigue, and a weakened immune system. Women who smoke and have HPV face a higher risk of developing cervical cancer than people who do not.

In conclusion, cervical cancer screening and HPV vaccination play crucial roles in the prevention and early detection of cervical cancer. By following the CDC's guidelines, women can significantly reduce their risk of developing cervical cancer and access early treatment if necessary, increasing their chances of survival.

  1. The Centers for Disease Control and Prevention (CDC) recommends a Pap smear every three years for women aged 21-29 years as a cervical cancer screening method.
  2. For women aged 30-65 years, the CDC offers multiple screening options: HPV testing alone every five years, co-testing (Pap smear plus HPV test) every five years, or a Pap smear alone every three years.
  3. The CDC recommends routine HPV vaccination for adolescents aged 11-12 years, with catch-up vaccination recommended for those who missed the vaccine at the recommended age, generally up to age 26.
  4. The vaccine currently available in the U.S. is Gardasil 9, which protects against 9 HPV types responsible for most cervical cancers and other HPV-related diseases.
  5. Women who smoke and have HPV face a higher risk of developing cervical cancer than those who do not.
  6. Regular cervical screening might help a person identify and deal with signs of cervical cancer before the condition can develop or spread too far, thereby increasing their chances of surviving the disease.

Read also:

    Latest